{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T10:55:06Z","timestamp":1777892106638,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.clinph.2026.2111589","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:17:19Z","timestamp":1769818639000},"page":"2111589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["High-density EEG in the eyes closed condition reveals early reduction of alpha oscillations after galcanezumab: A pilot study in migraine"],"prefix":"10.1016","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4762-4703","authenticated-orcid":false,"given":"Giulia","family":"Furregoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia","family":"Bernardelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4456-0560","authenticated-orcid":false,"given":"Marta","family":"Porro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Litterio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Massimini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Lovati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7486-7617","authenticated-orcid":false,"given":"Mario","family":"Rosanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clinph.2026.2111589_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.aprim.2021.102208","article-title":"Migraine review for general practice","volume":"54","author":"Aguilar-Shea","year":"2022","journal-title":"Atenci\u00f3n Primaria"},{"issue":"5","key":"10.1016\/j.clinph.2026.2111589_b0010","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3390\/jcm11051228","article-title":"Could the new anti-CGRP monoclonal antibodies be effective in migraine aura? Case reports and literature review","volume":"11","author":"Albanese","year":"2022","journal-title":"J. Clin. Med."},{"issue":"8","key":"10.1016\/j.clinph.2026.2111589_b0015","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(19)30185-1","article-title":"Migraine and the trigeminovascular system\u201440 years and counting","volume":"18","author":"Ashina","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clinph.2026.2111589_b0020","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.77146","article-title":"Migraine monoclonal antibodies against CGRP change brain activity depending on ligand or receptor target \u2013 an fMRI study","volume":"11","author":"Basedau","year":"2022","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.clinph.2026.2111589_b0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. Roy. Stat. Soc.: Ser. B (Methodol.)"},{"issue":"3","key":"10.1016\/j.clinph.2026.2111589_b0030","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.clinph.2008.11.018","article-title":"The occipital alpha rhythm related to the \u201cmigraine cycle\u201d and headache burden: a blinded, controlled longitudinal study","volume":"120","author":"Bj\u00f8rk","year":"2009","journal-title":"Clin. Neurophysiol."},{"issue":"17","key":"10.1016\/j.clinph.2026.2111589_b0035","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1523\/JNEUROSCI.0373-15.2015","article-title":"Migraine: multiple processes, complex pathophysiology","volume":"35","author":"Burstein","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clinph.2026.2111589_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2022.109486","article-title":"The rt-TEP tool: real-time visualization of TMS-evoked potentials to maximize cortical activation and minimize artifacts","volume":"370","author":"Casarotto","year":"2022","journal-title":"J. Neurosci. Methods"},{"issue":"10","key":"10.1016\/j.clinph.2026.2111589_b0045","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/head.13695","article-title":"A popperian view on anti\u2010CGRP biologics in migraine","volume":"59","author":"Chiarugi","year":"2019","journal-title":"Headache: J Head Face Pain"},{"issue":"9","key":"10.1016\/j.clinph.2026.2111589_b0050","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1177\/0333102420914913","article-title":"No central action of CGRP antagonising drugs in the GTN mouse model of migraine","volume":"40","author":"Christensen","year":"2020","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.clinph.2026.2111589_b0055","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s10548-008-0061-6","article-title":"Three-dimensional localization of abnormal EEG activity in migraine: a low resolution electromagnetic tomography (LORETA) study of migraine patients in the pain-free interval","volume":"21","author":"Clemens","year":"2008","journal-title":"Brain Topogr."},{"issue":"11","key":"10.1016\/j.clinph.2026.2111589_b0060","doi-asserted-by":"crossref","first-page":"7193","DOI":"10.1093\/cercor\/bhad031","article-title":"Beyond alpha power: EEG spatial and spectral gradients robustly stratify disorders of consciousness","volume":"33","author":"Colombo","year":"2023","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.clinph.2026.2111589_b0065","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuroimage.2019.01.024","article-title":"The spectral exponent of the resting EEG indexes the presence of consciousness during unresponsiveness induced by propofol, xenon, and ketamine","volume":"189","author":"Colombo","year":"2019","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.clinph.2026.2111589_b0070","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s10194-022-01421-z","article-title":"Central effects of galcanezumab in migraine: a pilot study on steady state visual evoked potentials and occipital hemodynamic response in migraine patients","volume":"23","author":"de Tommaso","year":"2022","journal-title":"J. Headache Pain"},{"issue":"24","key":"10.1016\/j.clinph.2026.2111589_b0075","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000006640","article-title":"Galcanezumab in chronic migraine: the randomized, double-blind, placebo-controlled REGAIN study","volume":"91","author":"Detke","year":"2018","journal-title":"Neurology"},{"issue":"S1","key":"10.1016\/j.clinph.2026.2111589_b0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/head.13300","article-title":"A phase\u2010by\u2010phase review of migraine pathophysiology","volume":"58","author":"Dodick","year":"2018","journal-title":"Headache: J Head Face Pain"},{"issue":"12","key":"10.1016\/j.clinph.2026.2111589_b0085","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/s41593-020-00744-x","article-title":"Parameterizing neural power spectra into periodic and aperiodic components","volume":"23","author":"Donoghue","year":"2020","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.clinph.2026.2111589_b0090","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/ph14030245","article-title":"The role of galcanezumab in migraine prevention: existing data and future directions","volume":"14","author":"Gklinos","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.clinph.2026.2111589_b0095","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.410280213","article-title":"Vasoactive peptide release in the extracerebral circulation of humans during migraine headache","volume":"28","author":"Goadsby","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clinph.2026.2111589_b0100","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s10194-022-01518-5","article-title":"The premonitory phase of migraine is due to hypothalamic dysfunction: revisiting the evidence","volume":"23","author":"Gollion","year":"2022","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.clinph.2026.2111589_b0105","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS). (2018). The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 38(1), 1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202.","DOI":"10.1177\/0333102417738202"},{"issue":"1","key":"10.1016\/j.clinph.2026.2111589_b0110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/155005949002100110","article-title":"Brain mapping in migraine","volume":"21","author":"Hughes","year":"1990","journal-title":"Clin. Electroencephalogr."},{"issue":"5","key":"10.1016\/j.clinph.2026.2111589_b0115","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/head.13529","article-title":"CGRP and the trigeminal system in migraine","volume":"59","author":"Iyengar","year":"2019","journal-title":"Headache: J. Head Face Pain"},{"issue":"10","key":"10.1016\/j.clinph.2026.2111589_b0120","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1177\/0333102419844711","article-title":"Peripheral and central nervous system distribution of the CGRP neutralizing antibody [125I] galcanezumab in male rats","volume":"39","author":"Johnson","year":"2019","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.clinph.2026.2111589_b0125","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1468-2982.2002.00310.x","article-title":"CGRP may play a causative role in migraine","volume":"22","author":"Lassen","year":"2002","journal-title":"Cephalalgia"},{"issue":"13","key":"10.1016\/j.clinph.2026.2111589_b0130","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1177\/0333102419867280","article-title":"Hypothalamic regulation of headache and migraine","volume":"39","author":"May","year":"2019","journal-title":"Cephalalgia"},{"issue":"10","key":"10.1016\/j.clinph.2026.2111589_b0135","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S1474-4422(20)30279-9","article-title":"Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER)","volume":"19","author":"Mulleners","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clinph.2026.2111589_b0140","series-title":"Electroencephalography: Basic Principles, Clinical Applications, and Related Fields","author":"Niedermeyer","year":"2004"},{"issue":"1","key":"10.1016\/j.clinph.2026.2111589_b0145","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s10194-021-01322-7","article-title":"Efficacy of galcanezumab in patients with migraine and history of failure to 3\u20134 preventive medication categories","volume":"22","author":"Okonkwo","year":"2021","journal-title":"J. Headache Pain"},{"issue":"7","key":"10.1016\/j.clinph.2026.2111589_b0150","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/j.pain.0000000000002516","article-title":"Resting-state occipital alpha power is associated with treatment outcome in patients with chronic migraine","volume":"163","author":"Pan","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.clinph.2026.2111589_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.801437","article-title":"Mechanical punctate pain thresholds in patients with migraine across different migraine phases","volume":"12","author":"Pan","year":"2022","journal-title":"Front. Neurol."},{"issue":"13","key":"10.1016\/j.clinph.2026.2111589_b0160","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.3390\/app13137443","article-title":"Quantitative electroencephalographic analysis in women with migraine during the luteal phase","volume":"13","author":"Pelayo-Gonz\u00e1lez","year":"2023","journal-title":"Appl. Sci."},{"issue":"8","key":"10.1016\/j.clinph.2026.2111589_b0165","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/0333102419898868","article-title":"Redefining migraine phases","volume":"40","author":"Peng","year":"2020","journal-title":"Cephalalgia"},{"issue":"8","key":"10.1016\/j.clinph.2026.2111589_b0170","article-title":"Electrophysiological findings in migraine","volume":"43","author":"Puledda","year":"2023","journal-title":"Cephalalgia"},{"issue":"7","key":"10.1016\/j.clinph.2026.2111589_b0175","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/brain\/aww097","article-title":"The migraine generator revisited","volume":"139","author":"Schulte","year":"2016","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.clinph.2026.2111589_b0180","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamaneurol.2017.3859","article-title":"Effect of different doses of galcanezumab vs placebo for episodic migraine prevention","volume":"75","author":"Skljarevski","year":"2018","journal-title":"JAMA Neurol."},{"issue":"1\u20132","key":"10.1016\/j.clinph.2026.2111589_b0185","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0013-4694(64)90038-0","article-title":"The EEG in migraine","volume":"16","author":"Smyth","year":"1964","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.clinph.2026.2111589_b0190","article-title":"Migraine attacks as a result of hypothalamic loss of control","volume":"32","author":"Stankewitz","year":"2021","journal-title":"NeuroImage: Clin."},{"issue":"1","key":"10.1016\/j.clinph.2026.2111589_b0195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0304-3959(00)00305-5","article-title":"Validity of the migraine disability assessment (MIDAS) score","volume":"88","author":"Stewart","year":"2000","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.clinph.2026.2111589_b0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s10194-021-01364-x","article-title":"Preventive treatment with CGRP monoclonal antibodies restores brain stem habituation deficits","volume":"22","author":"Thiele","year":"2021","journal-title":"J. Headache Pain"},{"issue":"1","key":"10.1016\/j.clinph.2026.2111589_b0205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/j.pain.0000000000001384","article-title":"Chronic pain as a symptom or a disease","volume":"160","author":"Treede","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.clinph.2026.2111589_b0210","unstructured":"U.S. Food and Drug Administration. (2018). Clinical pharmacology and biopharmaceutics review: Galcanezumab (NDA 761063)."},{"issue":"12","key":"10.1016\/j.clinph.2026.2111589_b0215","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.biopsych.2015.04.016","article-title":"Dynamic network communication as a unifying neural basis for cognition","volume":"77","author":"Voytek","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.clinph.2026.2111589_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2023.1082317","article-title":"Application of EEG in migraine","volume":"17","author":"Zhang","year":"2023","journal-title":"Front. Hum. Neurosci."}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138824572600088X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138824572600088X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:19:43Z","timestamp":1777616383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138824572600088X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":44,"alternative-id":["S138824572600088X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2026.2111589","relation":{},"ISSN":["1388-2457"],"issn-type":[{"value":"1388-2457","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-density EEG in the eyes closed condition reveals early reduction of alpha oscillations after galcanezumab: A pilot study in migraine","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2026.2111589","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of International Federation of Clinical Neurophysiology.","name":"copyright","label":"Copyright"}],"article-number":"2111589"}}